Prostate cancer: Three drug trials to watch

By Yahoo! Finance | Nov 19, 2024 at 04:00 AM EST

Clinical trials for prostate cancer treatments are being closely monitored. Johnson & Johnson's Akeega trial focuses on a dual-action tablet, while Pfizer's trial investigates an EZH2 inhibitor. These studies aim to improve outcomes for patients with advanced prostate cancer.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.